Ligand Pharmaceuticals Inc. | Cash Flow
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
8,832.00
10,892.00
227,444.00
2,367.00
12,556.00
143,321
Depreciation, Depletion & Amortization
2,663.00
2,657.00
2,627.00
11,290.00
11,714.00
14,718
Other Funds
-
48,143.00
-
999.00
10,074.00
48,066
Funds from Operations
21,392.00
31,515.00
40,906.00
73,621.00
105,006.00
235,844
Changes in Working Capital
702.00
10,949.00
440.00
10,620.00
11,438.00
41,785
Net Operating Cash Flow
20,690.00
20,566.00
40,466.00
63,001.00
93,568.00
194,059
Capital Expenditures
3,948.00
1,006.00
4,123.00
19,545.00
2,156.00
Sale of Fixed Assets & Businesses
3.00
125.00
-
-
-
Purchase/Sale of Investments
-
2,342.00
92,752.00
22,668.00
57,624.00
Net Investing Cash Flow
4,974.00
2,027.00
112,862.00
143,192.00
84,177.00
Issuance/Reduction of Debt, Net
19,586.00
229,923.00
-
-
-
Net Financing Cash Flow
16,458.00
130,025.00
8,360.00
1,515.00
7,523.00
Net Change in Cash
742.00
148,564.00
64,036.00
78,676.00
1,868.00
Free Cash Flow
20,313.00
20,560.00
40,373.00
61,151.00
91,412.00
Deferred Taxes & Investment Tax Credit
374.00
410.00
192,132.00
10,697.00
44,518.00
29,739
Net Assets from Acquisitions
989.00
-
-
92,502.00
26,653.00
Other Sources
-
5.00
-
300.00
7,254.00
Change in Capital Stock
3,128.00
51,755.00
8,360.00
2,514.00
2,551.00
Other Uses
40.00
3,493.00
15,987.00
8,777.00
4,998.00
About Ligand Pharmaceuticals
View Profile
